Aberdeen Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-902,751
| Closed | -$48.9M | – | 945 |
|
|
2025
Q3 | $48.9M | Sell |
902,751
-80,297
| -8% | -$4.59M | 0.08% | 210 |
|
|
2025
Q2 | $54M | Buy |
983,048
+227,773
| +30% | +$13.4M | 0.09% | 193 |
|
|
2025
Q1 | $53.4M | Buy |
755,275
+59,473
| +9% | +$4M | 0.1% | 180 |
|
|
2024
Q4 | $45.7M | Buy |
695,802
+168,121
| +32% | +$11.3M | 0.09% | 219 |
|
|
2024
Q3 | $37.1M | Buy |
527,681
+33,240
| +7% | +$2.78M | 0.07% | 260 |
|
|
2024
Q2 | $40.7M | Buy |
494,441
+81,626
| +20% | +$6.8M | 0.08% | 242 |
|
|
2024
Q1 | $36.1M | Buy |
412,815
+36,577
| +10% | +$3.27M | 0.07% | 258 |
|
|
2023
Q4 | $36.3M | Buy |
376,238
+343,615
| +1,053% | +$30.4M | 0.08% | 257 |
|
|
2023
Q3 | $2.89M | Sell |
32,623
-109
| -0.3% | -$9.7K | 0.01% | 645 |
|
|
2023
Q2 | $2.84M | Sell |
32,732
-284
| -0.9% | -$26.7K | 0.01% | 675 |
|
|
2023
Q1 | $3.21M | Buy |
33,016
+15,387
| +87% | +$1.6M | 0.01% | 654 |
|
|
2022
Q4 | $1.82M | Buy |
17,629
+1,122
| +7% | +$105K | 0.01% | 713 |
|
|
2022
Q3 | $1.4M | Sell |
16,507
-8,540
| -34% | -$760K | ﹤0.01% | 747 |
|
|
2022
Q2 | $2.08M | Buy |
25,047
+1,989
| +9% | +$158K | 0.01% | 706 |
|
|
2022
Q1 | $1.79M | Buy |
23,058
+2,849
| +14% | +$238K | ﹤0.01% | 752 |
|
|
2021
Q4 | $1.79M | Buy |
20,209
+851
| +4% | +$70.2K | ﹤0.01% | 797 |
|
|
2021
Q3 | $1.5M | Buy |
19,358
+3,431
| +22% | +$271K | ﹤0.01% | 833 |
|
|
2021
Q2 | $1.33M | Sell |
15,927
-3,175
| -17% | -$252K | ﹤0.01% | 838 |
|
|
2021
Q1 | $1.44M | Buy |
19,102
+405
| +2% | +$33.1K | ﹤0.01% | 814 |
|
|
2020
Q4 | $1.64M | Buy |
18,697
+390
| +2% | +$30.9K | ﹤0.01% | 773 |
|
|
2020
Q3 | $1.39M | Sell |
18,307
-5,112
| -22% | -$517K | ﹤0.01% | 756 |
|
|
2020
Q2 | $2.89M | Sell |
23,419
-362
| -2% | -$36K | 0.01% | 644 |
|
|
2020
Q1 | $2.01M | Sell |
23,781
-257
| -1% | -$22.1K | 0.01% | 667 |
|
|
2019
Q4 | $2.03M | Buy |
24,038
+271
| +1% | +$20.5K | ﹤0.01% | 721 |
|
|
2019
Q3 | $1.6M | Buy |
23,767
+892
| +4% | +$68.7K | ﹤0.01% | 741 |
|
|
2019
Q2 | $1.96M | Buy |
22,875
+93
| +0.4% | +$7.96K | ﹤0.01% | 749 |
|
|
2019
Q1 | $2.02M | Buy |
22,782
+13,433
| +144% | +$1.24M | ﹤0.01% | 734 |
|
|
2018
Q4 | $785K | Sell |
9,349
-98
| -1% | -$9.32K | ﹤0.01% | 784 |
|
|
2018
Q3 | $916K | Sell |
9,447
-355
| -4% | -$35.4K | ﹤0.01% | 810 |
|
|
2018
Q2 | $923K | Buy |
+9,802
| New | +$858K | ﹤0.01% | 805 |
|
Other funds holding BMRN
